N95 grade medical protective masks are air purifying personal protective devices, which are designed for reducing the users’ inhalation exposure to certain airborne particles. These respirators are tested and certified by the National Institute for Occupational Safety and Health (NIOSH) - a Department of Health and Human Services.
The global N95 grade medical protective masks market is projected to reach around US$ 1,495.4 million by the end of 2027, in terms of revenue, exhibiting a CAGR of 7.3% during the forecast period (2020-2027).
As the countries across the globe are dealing with new pandemic- COVID-19, there is an increased need of protection for dealing with such virus. The emergence of this pandemic has led to a drastic increase in demand of masks. China contributes significantly to the global production of N95 masks. However, after the COVID-19 pandemic broke out, there was temporary shutdown of factories, which resulted in temporary disruption in the production of masks. When the epidemic was under control, the factories started commencing its operations slowly. However, it was not possible for China to fulfill the local demand and the global orders. With the objective of compacting this difficult situation, the factories engaged in production of phones and cars turned for producing masks. Furthermore, the machines that were used for churning the fibrous material for diapers and sanitary pads were re-tooled for producing the materials required for masks.
Among region, North America held dominant position in the global N95 grade medical protective masks market in 2018, accounting for 38.5% share in terms of value, followed by Asia Pacific.
Figure 1. Global N95 Grade Medical Protective Masks Market Revenue Share (%), By Region, 2018
The availability of medical, surgical, and patient care face masks are major factors restraining growth of the N95 grade medical protective masks market. The medical and surgical masks are designed in a manner, which helps in the prevention of larger droplets from being expelled by the wearer into the environment. The small players in the market also manufacture masks similar to N95 respirators, however they are not capable of protecting the wearer from inhalation of airborne hazards. These substitutes pose a great threat to the market.
The N95 grade medical protective masks market is expected to witness significant growth opportunities with the increasing adoption of safety healthcare protective devices, owing to rising awareness amongst the people about the benefits offered by N95 masks. As per China standards, KN95 is the equivalent respirator of N95. In the ongoing COVID-19 pandemic, China is one of the worst affected countries and is producing the masks at a rapid rate.
Figure 2. Global N95 Grade Medical Protective Masks Market – Opportunity Analysis
The World Health Organization reported a total of 413,467 cases across the globe as on March 25, 2020. Among this, the major affected countries include China (81,848 cases), Italy (69,176 cases), USA (68334 cases), Iran (24,811 cases), Republic of Korea (9,137 cases), Spain (39,673 cases), Germany (31,554 cases), and France (22,025 cases). There is a drastic increase in the number of cases in several economies across the globe. This increasing pandemic has led to rising demand for personal protective equipment. Furthermore, the World Health Organization projected that the frontline health responders across the globe would require 89 million masks every month to protect themselves from the virus. This is projected to accelerate the market growth of N95 grade medical protective masks over the forecast period.
Figure 3. Global N95 Grade Medical Protective Masks Market Revenue Share (%), By Distribution Channel, 2019
Among distribution channel, in 2019, the hospitals/clinics segment accounted for the largest market share of 58.4% in terms of value, followed by drug stores and online stores segments.
Key players operating in the global N95 grade medical protective masks market include The 3M Company, Honeywell International Inc., Kimberly-Clark Corporation, Cardinal Health, Inc., Kowa Company Ltd., Shanghai Dasheng, Vogmask, Hakugen Co. Ltd, Sinotextiles Corporation Limited, and The Gerson Company.
N95 grade medical protective masks are respiratory protective devices, which are designed for efficient filtration of airborne particles. The N95 protective masks have the capability of blocking at least 95% of 0.3 micron particles. Also, the N95 respirators are not oil proof. If properly used by the user, N95 have superior filtration. N95 respirators, which are cleared by The Food and Drug Administration for use in health care settings, are called surgical N95 respirators.
The demand for N95 grade medical protective masks is expected to be driven by the increasing demand for personal protective equipment, owing to increasing air pollution causing respiratory infectious diseases. In a study by the World Health Organization (WHO), globally, around seven million people lost their lives annually due to breathing of contaminated air comprising high levels of pollutants that causes respiratory disorders. The respiratory diseases amongst the public is also increasing tremendously, which can be controlled by using the N95 grade respiratory protective mask.
Furthermore, Europe region is significantly contributing towards growth of the N95 grade medical protective masks market, owing to rapid increase in infections and non-communicable diseases (NCDs) such as influenza viral infections and cardiovascular diseases amongst others. According to WHO, in 2018, the European region experienced an increase in NCDs with around 77% of the disease burden, which contributed to an increase in demand for N95 grade medical protective masks for avoiding viral infections.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section